adamantane has been researched along with lignans in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allsopp, RC; Dayl, S; Evans, RJ; Schmid, R | 1 |
Alvarenga, GM; Chaves, OA; da Silva, JT; da Silveira, CH; de Andrade Querino, AL; de Magalhães, MTQ; Diniz, R; Iglesias, BA; Silva, H; Silva, JT | 1 |
2 other study(ies) available for adamantane and lignans
Article | Year |
---|---|
Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
Topics: Adamantane; Adenosine Triphosphate; Alleles; Allosteric Regulation; Allosteric Site; Amino Acid Sequence; Amino Acid Substitution; Aminoquinolines; Binding Sites; Humans; Ion Channel Gating; Lignans; Models, Molecular; Molecular Conformation; Mutation; Protein Binding; Protein Interaction Domains and Motifs; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Structure-Activity Relationship | 2017 |
Mono and dinuclear platinum and palladium complexes containing adamantane-azole ligands: DNA and BSA interaction and cytotoxicity.
Topics: Adamantane; Animals; Antineoplastic Agents; Azoles; Cell Line, Tumor; Cricetinae; DNA; Humans; Lignans; Mice; Molecular Docking Simulation; Nucleic Acid Conformation; Organoplatinum Compounds; Palladium | 2019 |